Growth Metrics

Cellectis (CLLS) Accumulated Depreciation & Amortization (2014 - 2025)

Cellectis (CLLS) posted Accumulated Depreciation & Amortization of -$11.3 million for Q4 2025, down 5.44% on a QoQ basis from -$10.7 million in Q4 2024, and down 5.44% year-over-year from -$12.0 million in Q4 2024.

Cellectis (CLLS) has 12 years of Accumulated Depreciation & Amortization data on file, last reported at -$11.3 million in Q4 2025.

  • In Q4 2025, Accumulated Depreciation & Amortization fell 5.44% year-over-year to -$11.3 million; the TTM figure through Dec 2025 stood at -$11.3 million (down 5.44% YoY), while the FY2025 annual figure was -$11.3 million, down 5.44% from the prior year.
  • Accumulated Depreciation & Amortization declined to -$11.3 million in Q4 2025, from -$10.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $11.2 million in Q4 2022 and bottomed at -$11.3 million in Q4 2025.
  • A 5-year average of -$2.7 million and a median of -$10.1 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
  • Annual changes were most pronounced in 2022 — Accumulated Depreciation & Amortization jumped 53.55% — and 2023, when it slumped 190.09%.
  • Year by year, Accumulated Depreciation & Amortization stood at $7.3 million in 2021, then jumped by 53.55% to $11.2 million in 2022, then tumbled by 190.09% to -$10.1 million in 2023, then retreated by 6.74% to -$10.7 million in 2024, then dropped by 5.44% to -$11.3 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at -$11.3 million (Q4 2025), -$10.7 million (Q4 2024), and -$10.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Cellectis 20.83 Bn 20.62 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -11.33 Mn
Dec 31, 2025 -11.33 Mn
Dec 31, 2024 -10.74 Mn
Dec 31, 2024 -10.74 Mn
Dec 31, 2023 -10.06 Mn
Dec 31, 2023 -10.06 Mn
Dec 31, 2022 11.17 Mn
Dec 31, 2022 11.17 Mn
Dec 31, 2021 7.28 Mn
Dec 31, 2021 7.28 Mn
Dec 31, 2020 21.37 Mn
Dec 31, 2020 21.37 Mn
Dec 31, 2019 17.82 Mn
Dec 31, 2019 17.82 Mn
Dec 31, 2018 17.43 Mn
Dec 31, 2018 17.43 Mn
Dec 31, 2017 14.88 Mn
Dec 31, 2017 14.88 Mn
Dec 31, 2016 411,218.45
Dec 31, 2016 411,218.45
Dec 31, 2015 37,719.43
Dec 31, 2015 37,719.43
Dec 31, 2014 93,065.39
Dec 31, 2014 93,065.39